Anticonvulsant-induced osteomalacia. Vitamin D metabolism disorders in epileptics on anticonvulsant therapy
Christiansen, C.; Rødbro, P.
Ugeskrift for Laeger 141(5): 280-284
1979
ISSN/ISBN: 0041-5782 PMID: 760307 Document Number: 143252
Document emailed within 1 workday
Related Documents
Chambourlier, P.; Pinot, J.J.; Argemi, B.; Sardo, B.; Mongin, M. 1978: Bourneville's tuberous sclerosis of late onset and anticonvulsant-induced osteomalacia Annales de Medecine Interne 129(6-7): 455-458Hoikka, V.; Savolainen, K.; Karjalainen, P.; Alhava, E.M.; Sivenius, J. 1982: Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy Annals of Clinical Research 14(2): 72-75
Frey, O.R. 2001: Anticonvulsant weaning? how should anticonvulsant therapy be discontinued? Medizinische Monatsschrift für Pharmazeuten 24(8): 266
Adair, I.V. 1975: Anticonvulsant osteomalacia Journal of the Royal College of Surgeons of Edinburgh 20(6): 380-383
Broeker, H. 1980: The contribution of blood anticonvulsant determination to the evaluation of fitness to drive in epileptics Zeitschrift für Arztliche Fortbildung 74(23): 1112-1116
Santucci, A.; Caputo, V.; Cicconetti, P.; Bucci, A.; Aguglia, F. 1978: A case of osteomalacia secondary to prolonged treatment with anticonvulsant drugs La Clinica Terapeutica 85(6): 573-590
Goodwin, F.K. 1999: Anticonvulsant therapy and suicide risk in affective disorders Journal of Clinical Psychiatry 60(Suppl): 89-93; Discussion 111-116
Bergonzi, P.; De Rosa, G.; Mazza, S.; Mennuni, G.; Zuppi, P.L. 1979: Long-term anticonvulsant therapy and calcium and phosphorus metabolism Rivista di Neurologia 49(1): 72-81
Graziani, G.; Tirone, F.; Barbadoro, E.; Testa, R. 1983: Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile Arzneimittel-Forschung 33(8): 1155-1160
Scharla, S. 2008: Diagnosis of Disorders of Vitamin D-Metabolism and Osteomalacia Clinical Laboratory 54(11-12): 451-459
Tebloeva, L.T.; Fedorov, A.M. 1982: Rickets in children induced by anticonvulsant therapy Pediatriia 6: 75-77
Alexandropoulou, P.; Mauri, D.; Rigatou, E.; Karampoiki, V. 2000: Hyperpyrexia secondary to acute hypocalcemic status. Is there a role for calcitonin therapy in bone metabolism derangements due to anticonvulsant drugs? Minerva Medica 91(11-12): 321-323
David, H.P.; Woloszczuk, W.; Kovarik, J. 1983: Antiepileptic-induced osteomalacia and vitamin D therapy Der Nervenarzt 54(12): 647-650
Stiff, D.D.; Zemaitis, M.A. 1990: Metabolism of the anticonvulsant agent zonisamide in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 888-894
Hempel, R.; Schupke, H.; McNeilly, P.J.; Heinecke, K.; Kronbach, C.; Grunwald, C.; Zimmermann, G.; Griesinger, C.; Engel, J.; Kronbach, T. 1999: Metabolism of retigabine (D-23129), a novel anticonvulsant Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(5): 613-622
Woody, R.C. 1984: Recent advances in anticonvulsant management of childhood seizure disorders Journal of the Arkansas Medical Society 80(9): 404-407
Evins, A.E. 2003: Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders Journal of Clinical Psychiatry 64(Suppl 8): 9-14
Inoue, F. 1982: Clinical implications of anticonvulsant-induced folate deficiency Clinical Pharmacy 1(4): 372-373
Iwata, Y.; Amano, K.; Kawamura, H.; Tanikawa, T.; Kawabatake, H.; Notani, M.; Iseki, H.; Shiwaku, T.; Nagao, T.; Taira, T. 1985: Evaluation of anticonvulsant-induced bone changes by a microdensitometric method No Shinkei Geka. Neurological Surgery 13(3): 293-299
Martin, S.W.; Bishop, F.E.; Kerr, B.M.; Moor, M.; Moore, M.; Sheffels, P.; Rashed, M.; Slatter, J.G.; Berthon-Cédille, L.; Lepage, F.; Descombe, J.J.; Picard, M.; Baillie, T.A.; Levy, R.H. 1997: Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(1): 40-46